IFNA1 and cancer: Cancer patients tend to have weaker responses to viral infections [7], mostly due to impaired responses of type I interferon (IFN) that are typical of cancers [12] and diverse immune cell dysfunctions that are frequent adverse effects of oncologic treatments.